000302790 001__ 302790
000302790 005__ 20250829103033.0
000302790 0247_ $$2doi$$a10.1016/j.dld.2025.06.005
000302790 0247_ $$2pmid$$apmid:40582954
000302790 0247_ $$2ISSN$$a1590-8658
000302790 0247_ $$2ISSN$$a1878-3562
000302790 0247_ $$2altmetric$$aaltmetric:178499010
000302790 037__ $$aDKFZ-2025-01330
000302790 041__ $$aEnglish
000302790 082__ $$a610
000302790 1001_ $$aSirtl, Simon$$b0
000302790 245__ $$aLower rate of pancreatobiliary complications after sludge and microlithiasis pancreatitis compared to gallstone pancreatitis.
000302790 260__ $$a[Erscheinungsort nicht ermittelbar]$$bSaunders$$c2025
000302790 3367_ $$2DRIVER$$aarticle
000302790 3367_ $$2DataCite$$aOutput Types/Journal article
000302790 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1756456189_12781
000302790 3367_ $$2BibTeX$$aARTICLE
000302790 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000302790 3367_ $$00$$2EndNote$$aJournal Article
000302790 500__ $$aVolume 57, Issue 9, September 2025, Pages 1810-1818
000302790 520__ $$aCholecystectomy is recommended to prevent recurrence of biliary pancreatitis, but supporting evidence is limited for sludge- and microlithiasis-induced acute pancreatitis (AP). This study aimed to compare relapse patterns and risk factors between patients with sludge/microlithiasis-induced AP and gallstone-induced AP.This analysis included 789 patients from the international, multicenter Relapstone cohort (Spain: 16 centers; Mexico: 2 centers), hospitalized between January 2018 and April 2020 with first-time biliary AP and no cholecystectomy during admission. Patients with sludge/microlithiasis-induced AP (n = 274) were compared to those with gallstone-induced AP (n = 515) regarding pancreatobiliary complications. Multivariate analysis was used to assess relapse risk factors.Pancreatobiliary complications occurred in 41.7 % of the gallstone cohort versus 32.1 % in the sludge/microlithiasis cohort (p = 0.01). Correspondingly, the gallstone AP cohort showed a significantly lower complication-free survival rate (log-rank p = 0.0022; median follow-up: 6.1 vs. 8.1 months). In multivariate analysis, older age in the gallstone group was significantly associated with lower relapse risk (HR = 0.54, 95 % CI: 0.39-0.74).This multicenter study reveals distinct differences in relapse risk between gallstone- and sludge/microlithiasis-induced AP, with gallstone AP showing a higher rate of complications in the absence of cholecystectomy.
000302790 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000302790 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000302790 650_7 $$2Other$$aAcute pancreatitis
000302790 650_7 $$2Other$$aBiliary pancreatitis
000302790 650_7 $$2Other$$aGallstones
000302790 650_7 $$2Other$$aMicrolithiasis
000302790 650_7 $$2Other$$aSludge
000302790 7001_ $$0P:(DE-HGF)0$$aTeodorescu, Bianca$$b1
000302790 7001_ $$aGilberg, Leonard$$b2
000302790 7001_ $$aSchäfer, Arlett$$b3
000302790 7001_ $$aBeyer, Georg$$b4
000302790 7001_ $$aArnau, Anna$$b5
000302790 7001_ $$aLópez-Guillén, Pablo$$b6
000302790 7001_ $$aMartínez-Domínguez, Samuel J$$b7
000302790 7001_ $$aBaroja, Daniel Abad$$b8
000302790 7001_ $$aOyón, Daniel$$b9
000302790 7001_ $$aRuiz-Belmonte, Lara M$$b10
000302790 7001_ $$aTejedor-Tejada, Javier$$b11
000302790 7001_ $$aZapater, Raul$$b12
000302790 7001_ $$aMartín-Vicente, Noelia$$b13
000302790 7001_ $$aFernández-Esparcia, Pedro José$$b14
000302790 7001_ $$aGomara, Ana Belén Julián$$b15
000302790 7001_ $$aLozano, Violeta Sastre$$b16
000302790 7001_ $$aGarcía, Juan José Manzanares$$b17
000302790 7001_ $$aMartín-Falquina, Irene Chivato$$b18
000302790 7001_ $$aPascual, Laura Andrés$$b19
000302790 7001_ $$aMonclus, Nuria Torres$$b20
000302790 7001_ $$aVelasco, Natividad Zaragoza$$b21
000302790 7001_ $$aRojo, Eukene$$b22
000302790 7001_ $$aLapeña-Muñoz, Berta$$b23
000302790 7001_ $$aFlores, Virginia$$b24
000302790 7001_ $$aGómez, Arantxa Díaz$$b25
000302790 7001_ $$aCañamares-Orbís, Pablo$$b26
000302790 7001_ $$aAbizanda, Isabel Vinzo$$b27
000302790 7001_ $$aCarrasco, Natalia Marcos$$b28
000302790 7001_ $$aGrau, Laura Pardo$$b29
000302790 7001_ $$aGarcía-Rayado, Guillermo$$b30
000302790 7001_ $$aBocos, Judith Millastre$$b31
000302790 7001_ $$ade Paredes, Ana Garcia Garcia$$b32
000302790 7001_ $$aLorenzo, María Vaamonde$$b33
000302790 7001_ $$aArostegi, Arantzazu Izagirre$$b34
000302790 7001_ $$aLozada-Hernández, Edgard Efrén$$b35
000302790 7001_ $$aVelasco, José Antonio Velarde-Ruiz$$b36
000302790 7001_ $$aŻorniak, Michal$$b37
000302790 7001_ $$ade-Madaria, Enrique$$b38
000302790 7001_ $$aMayerle, Julia$$b39
000302790 7001_ $$aVelamazán, Raúl$$b40
000302790 773__ $$0PERI:(DE-600)2061359-3$$a10.1016/j.dld.2025.06.005$$gp. S1590865825008096$$n9$$p1810-1818$$tDigestive and liver disease$$v57$$x1590-8658$$y2025
000302790 909CO $$ooai:inrepo02.dkfz.de:302790$$pVDB
000302790 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000302790 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000302790 9141_ $$y2025
000302790 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-05
000302790 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-05
000302790 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-05
000302790 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-05
000302790 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-05
000302790 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-05
000302790 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-05
000302790 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-05
000302790 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-05
000302790 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bDIGEST LIVER DIS : 2022$$d2024-12-05
000302790 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-05
000302790 9201_ $$0I:(DE-He78)MU01-20160331$$kMU01$$lDKTK Koordinierungsstelle München$$x0
000302790 980__ $$ajournal
000302790 980__ $$aVDB
000302790 980__ $$aI:(DE-He78)MU01-20160331
000302790 980__ $$aUNRESTRICTED